Literature DB >> 31497214

MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2.

Lingqi Liu1, Liang Chen1, Tianpeng Wu1, Huijun Qian1, Sixing Yang1.   

Abstract

The expression and function of microRNA (miR)-30a-3p in several types of human cancer have been explored. However, the biological function of miR-30a-3p in renal cell carcinoma (RCC) remains largely unknown. In this study, we demonstrate that expression of miR-30a-3p is down-regulated in RCC tissues compared to adjacent normal tissues. Furthermore, ectopic expression of miR-30a-3p significantly suppressed the proliferation, migration, and invasion of a human RCC cell line in vitro, while miR-30a-3p inhibited tumor growth in vivo as well. TargetScan software identified Wnt2 as a potential direct target of miR-30a-3p. To confirm this relationship, Wnt2 was ectopically expressed. The effects of miR-30a-3p on RCC cell proliferation and invasion were subsequently restored. Therefore, the results of this study support an anti-tumor role for miR-30a-3p in RCC progression which is potentially mediated via Wnt2.

Entities:  

Keywords:  MicroRNA-30a-3p; Renal cell carcinoma; WNT2

Year:  2019        PMID: 31497214      PMCID: PMC6731429     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

1.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

2.  Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway.

Authors:  Chongbiao Huang; Ruijue Ma; Yong Xu; Na Li; Zengxun Li; Jie Yue; Haixin Li; Yan Guo; Daliang Qi
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 3.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 4.  Signaling pathways in renal cell carcinoma.

Authors:  Gowrishankar Banumathy; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

5.  Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells.

Authors:  Yong Xu; Hua Li; Chongbiao Huang; Tiansuo Zhao; Huan Zhang; Chen Zheng; He Ren; Jihui Hao
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

6.  MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.

Authors:  Bing Zheng; Hua Zhu; Donghua Gu; Xiaodong Pan; Lin Qian; Boxin Xue; Dongrong Yang; Jundong Zhou; Yuxi Shan
Journal:  Biochem Biophys Res Commun       Date:  2015-02-21       Impact factor: 3.575

7.  ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.

Authors:  Lingqi Liu; Junkui Ai; Wuhan Xiao; June Liu; Yujuan Wang; Dianqi Xin; Zhisong He; Yinglu Guo; Zhou Wang
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

8.  MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Authors:  W Wang; H Lin; L Zhou; Q Zhu; S Gao; H Xie; Z Liu; Z Xu; J Wei; X Huang; S Zheng
Journal:  Eur J Surg Oncol       Date:  2013-11-19       Impact factor: 4.424

Review 9.  Cytoreductive nephrectomy for metastatic renal cell carcinoma: a review of the historical literature and its role in the era of targeted molecular therapy.

Authors:  Muhammad Z Aslam; P N Matthews
Journal:  ISRN Urol       Date:  2014-01-23

Review 10.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

View more
  5 in total

1.  MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling.

Authors:  Dongxiao Ding; Yunqiang Zhang; Xuede Zhang; Ke Shi; Wenjun Shang; Junjie Ying; Li Wang; Zhongjie Chen; Haihua Hong
Journal:  Mol Biotechnol       Date:  2022-04-19       Impact factor: 2.860

2.  Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer.

Authors:  Yan Liu; Meng Gao; Juan An; Xin Wang; Yan Jia; Junfeng Xu; Jihai Zhu; Jiantao Cui; Wenmei Li; Rui Xing; Li Song; Kejia Liu; Yuqi He; Jianqiu Sheng; Shengmei Qi; Yuanming Pan; Youyong Lu
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

3.  SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.

Authors:  Hongyuan Yu; Junlong Liu; Zhe Zhang; Yuyan Zhu; Jianbin Bi; Chuize Kong
Journal:  J Cell Mol Med       Date:  2021-03-30       Impact factor: 5.310

4.  MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2.

Authors:  XueMei Yang; JiaLing Sun; HaiTao Sun; Bin Wen; MingJia Zhang; HaiYan An; WeiCong Chen; WenTing Zhao; XiaoDan Zhong; ChunYu He; Jie Pang; SongQi He
Journal:  J Cancer       Date:  2021-05-10       Impact factor: 4.207

5.  MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.

Authors:  Yangfeng Shi; Yiming Xu; Jianchang Yao; Chao Yan; Hua Su; Xue Zhang; Enguo Chen; Kejing Ying
Journal:  J Cell Mol Med       Date:  2021-06-13       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.